Showing Results for
- Academic Journals (81)
Search Results
- 81
Academic Journals
- 81
- Search Terms:
- 1From: Genome Medicine. (Vol. 3, Issue 26) Peer-ReviewedClassical Hodgkin lymphoma is considered a highly curable disease; however, 20% of patients cannot be cured with standard first-line chemotherapy and have a dismal outcome. Current clinical parameters do not allow...
- 2From: Genome Medicine. (Vol. 3, Issue 66) Peer-Reviewed
- 3From: Genome Medicine. (Vol. 3, Issue 37) Peer-Reviewed
- 4From: Genome Medicine. (Vol. 3, Issue 69) Peer-Reviewed
- 5From: Genome Medicine. (Vol. 3) Peer-ReviewedBackground Pharmacogenetic testing holds major promise in allowing physicians to tailor therapy to patients based on genotype. However, there is little data on the impact of pharmacogenetic test results on patient...
- 6From: Genome Medicine. (Vol. 3) Peer-ReviewedWe propose an innovative, integrated, cost-effective health system to combat major non-communicable diseases (NCDs), including cardiovascular, chronic respiratory, metabolic, rheumatologic and neurologic disorders and...
- 7From: Genome Medicine. (Vol. 3, Issue 79) Peer-Reviewed
- 8From: Genome Medicine. (Vol. 3, Issue 14) Peer-Reviewed
- 9From: Genome Medicine. (Vol. 3, Issue 17) Peer-Reviewed
- 10From: Genome Medicine. (Vol. 3, Issue 52) Peer-Reviewed
- 11From: Genome Medicine. (Vol. 3, Issue 44) Peer-ReviewedAuthor(s): M William Lensch1,2,3 The importance of stem cells and genomics for translational research The confluence of human stem cell and genome research is laden with opportunity. Information gleaned from the...
- 12From: Genome Medicine. (Vol. 3, Issue 38) Peer-Reviewed
- 13From: Genome Medicine. (Vol. 3, Issue 36) Peer-Reviewed
- 14From: Genome Medicine. (Vol. 3, Issue 21) Peer-Reviewed
- 15From: Genome Medicine. (Vol. 3, Issue 41) Peer-Reviewed
- 16
- 17From: Genome Medicine. (Vol. 3, Issue 47) Peer-ReviewedInnovative 'systems' approaches to biomedical research offer substantial promise for advancing knowledge and improving health care, as outlined by Bousquet et al. in this issue. However, they are unlikely to improve...
- 18From: Genome Medicine. (Vol. 3) Peer-ReviewedBackground Organic cation transporters (OCTs) determine not only physiological processes but are also involved in the cellular uptake of anticancer agents. Based on microarray analyses in hepatocellular carcinoma...
- 19From: Genome Medicine. (Vol. 3, Issue 55) Peer-ReviewedHypoxia is a feature of most solid tumors and is associated with poor prognosis in several cancer types, including breast cancer. The master regulator of the hypoxic response is the Hypoxia-inducible factor 1[alpha]...
- 20From: Genome Medicine. (Vol. 3, Issue 4) Peer-Reviewed